Verapamil is a medication that belongs to a class of drugs called calcium channel blockers. It is used to treat high blood pressure, arrhythmias, and angina. The typical starting dose of verapamil for treating high blood pressure is 80 mg taken by mouth once daily. For treating arrhythmias, the starting dose is usually 120 mg taken by mouth three times daily. And for treating angina, the starting dose is 180 mg taken by mouth three times daily.
Some common side effects of verapamil include headache, dizziness, constipation, and nausea.
There are a few things to keep in mind when determining the right Verapamil dosage for you.They will also take into account any other medications you are taking, as well as any medical conditions you have. Based on all of this information, they will be able to determine the best dosage for you.
They may be able to adjust your dosage or give you suggestions on how to manage any side effects.
Verapamil is a medication that is used to treat high blood pressure, arrhythmias, and angina. While it is generally well-tolerated, there are some side effects that can occur. The most common side effects of verapamil include headache, dizziness, constipation, and fatigue. Other less common side effects include low blood pressure, fast heart rate, flushing, and nausea.
The long-term side effects of verapamil use are not well understood, but there have been reports of liver damage and rashes.
Verapamil is a powerful drug that can help manage symptoms of many conditions. However, if taken in too high of doses or for an extended period of time, it could be dangerous. We hope this guide has helped you understand more about verapamil dosage and how it can benefit you. If you have any further questions, speak with your physician before taking verapamil or adjusting your current dosage regimen.
1.
ALK-positive lung cancer trial results show unprecedented progression-free survival.
2.
The way that miR-377 inhibits cells that cause prostate cancer.
3.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
4.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
5.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
1.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
2.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
3.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
4.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
5.
Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation